PF-Atlas › Clinical Trials › NCT03999021

FIGHT-RP 1 Extension Study

NAC effervescent tablets · Phase 1

Registry ID
NCT03999021
Phase
Phase 1
Status
Active, not recruiting
Drug / intervention
NAC effervescent tablets
Sponsor
Johns Hopkins University
Start
2019-06-24

About this trial

NAC effervescent tablets is evaluated in NCT03999021, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Johns Hopkins University. Current status: Active, not recruiting.

View NCT03999021 on ClinicalTrials.gov →

Explore related

All NAC effervescent tablets trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT03999021 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.